Drug Shortage Report for CARBOPLATIN INJECTION BP

Last updated on 2023-05-17 History
Report ID 187124
Drug Identification Number 02126680
Brand name CARBOPLATIN INJECTION BP
Common or Proper name CARBOPLATIN INJECTION BP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CARBOPLATIN
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 60mL vial
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-29
Estimated end date
Actual end date 2023-05-16
Shortage status Resolved
Updated date 2023-05-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-05-17 English Compare
v10 2023-05-16 French Compare
v9 2023-05-16 English Compare
v8 2023-04-05 French Compare
v7 2023-04-05 English Compare
v6 2023-03-30 English Compare
v5 2023-03-29 French Compare
v4 2023-03-29 English Compare
v3 2023-03-29 English Compare
v2 2023-03-15 French Compare
v1 2023-03-15 English Compare

Showing 1 to 11 of 11